Primary pulmonary hypertension;Hypertension arterielle pulmonaire primitive

Presse Medicale

Volumn 27, Issue 10, 1998, Pages 489-495

  Pointet, P ^a   Jebrak G ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENYLATE CYCLASE; AMPHETAMINE DERIVATIVE; CARDIAC GLYCOSIDE; DEXFENFLURAMINE; DIURETIC AGENT; ENDOTHELIUM DERIVED RELAXING FACTOR; FENFLURAMINE; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; VASODILATOR AGENT; ANOREXIGENIC AGENT;

CATHETERIZATION; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; HEMODYNAMICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG ANGIOGRAPHY; LUNG FUNCTION; LUNG SCINTISCANNING; LUNG TRANSPLANTATION; PATHOPHYSIOLOGY; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; THORAX RADIOGRAPHY; THROMBOCYTE; VASCULAR ENDOTHELIUM; ADULT; DYSPNEA; EXERCISE; FOLLOW UP; HEART CATHETERIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHYSIOLOGY; PORTAL HYPERTENSION; PULMONARY ARTERY;

ADULT; APPETITE DEPRESSANTS; BLOOD PLATELETS; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; EXERTION; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEMODYNAMIC PROCESSES; HIV INFECTIONS; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; PROGNOSIS; PULMONARY ARTERY; VASODILATOR AGENTS;

EID: 0032515718     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Abenhaim L, Moride Y, Brenot F et al. Appetite suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996;335:609-15.
2. Brenot F. Primary pulmonary hypertension. Case series from France. Chest 1994;105:suppl s33-6.
3. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Int Med 1987;107:216-23.
4. d'Alonzo GE, Barst RJ, Ayres SM et al. Survival in patient with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115:343-9.
5. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl N Med 1995;333:214-21.
6. Giaid A, Yanagisawa M, Langleben D et al. Expression of endothelin in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732-9.
7. Christman BW, Mc Pherson CD, Newman JH et al. An imbalance between the excretion of thromboxane and prostacycline metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-5.
8. Cordier JF. Étiologies et physiopathologie des hypertensions artérielles pulmonaires (HTAP). Rev Prat 1991; 17:1534-40.
9. Brenot F, Hervé P, Rain B, Simonneau G. Hypertension artérielle pulmonaire primitive:données de la littérature et experience personnelle sur 125 cas en 10 ans. Rev Prat 1991;41:1560-7.
10. Thomson P, MacRae C. Familial Pulmonary Hypertension: evidence of autosomal dominant inheritance. Br Heart 1970;32:758-60.
11. Loyd JE, Butler MG, Foroud TM et al. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med 1995;152:93-7.
12. Rich S, Kieras K, Hart K et al. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 1986;8:1307-1311.
13. Kilbourne EM, Rigau-Perez JG, Heath WH et al. Clinical Epidemiology of Toxic-oil Syndrome:Manifestation of a New Illness. N Engl J Med 1983;309:1408-14.
14. Garda Dorado D, Miller DD, Garcia EJ et al. An epidemic of pulmonary hypertension of toxic rapeseed oil ingestion in Spain. J Am Coll Cardiol 1983;1:1216-22.
15. Mantze FA, Craige E. Portal Axis Thromboseis with Spontaneous Portocaval Shunt and Resulting Cor Pulmonale. Arch Path 1951;52:91-7.
16. MacDonnel PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis:are they related? Am Rev Respir Dis 1983;127:437-41.
17. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension:prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991;100:520-8.
18. Petitpretz P, Brenot F, Azarian R et al. Pulmonary hypertension in patients with human immunodeficiency virus infection:comparison with primary pulmonary hypertension. Circulation 1994;89:2722-7.
19. Kneussi MP, Lang IM, Brenot F. Medical management of primary pulmonary hypertension. Eur Respir J 1996; 9:2401-9.
20. Sitbon O, Brenot F, Denjean A et al. Nitric oxyde as a screening vasodilator in PPH: a dose response study and comparison with Prostacycline. Am J Respir Crit Care Med 1995;151:384-9.
21. Nootens M, Shrader B, Kaufman NE et al. Comparative acute effects of adenosine and prostacycline in primary Pulmonary hypertension. Chest 1995;107:54-7.
22. Rich S, Brundage BH. High dose calcium channel blocking therapy for primary pulmonary hypertension: evidence for longterm reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 1987;76:135-41.
23. Rich S, Kaufmann E, Levy PS. The effects of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
24. Barst RJ, Rubin LJ, MacGoon MD et al. Survival in primary pulmonary hypertension with long-term continuous intraveinous prostacyclin. Ann Intern Med 1994;121:409-15.
25. Moser KM, Fedullo PF, Finkbeiner WE et al. Do patients with primary pulmonary hypertension develop extensive central thrombi? Circulation 1995;91:741-5.
26. Hosenpud JD, Bennett LE, Keck BM et al. The registry of the international society for heart and lung transplantation fourteenth official report-1997. J Heart Transplant 1997;16:691-712.
27. Glanville AR, Burke CM, Theodore J, Robin ED. Primary pulmonary hypertension. Length of survival in patients referred for heart - lung transplantation. Chest 1987; 91:675-81.
28. Pointet P. Hypertension artérielle pulmonaire primitive et hypertension portale: étude rétrospective de 37 patients associant hypertension artérielle pulmonaire primitive et hypertension portale comparés à 216 patients atteints d'hypertension artérielle pulmonaire primitive. Thèse pour le Doctorat en Médecine. Paris, 1996.
29. Rubin LJ. ACCP Consensus Statement. Primary Pulmonary Hypertension. Chest 1993;104:236-50.
30. Sitbon O, Brenot F, Hervé et al. Pulmonary Hypertension Associated with Portal Hypertension. Comparaison with Primary Pulmonary Hypertension. Am J Respir Crit Care Med 1995,151:A723 (Abstract).